TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 16234141

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol (50 mug every 6 h for a maximum of two doses)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intracervical Foley balloon catheter (for 12 h followed by intravenous oxytocin infusion)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Intravaginal misoprostol
Number of subjects: 120

Group type: COMPARATOR
Intervention: Intracervical Foley balloon catheter
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 120
Study: 12163990

Group type: EXPERIMENTAL
Intervention: Selective lymph node dissection after hyperfractionated accelerated radio-(chemo-)therapy
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Selective lymph node dissection
Number of subjects: 87

Group type: COMPARATOR
Intervention: Hyperfractionated accelerated radio-(chemo-)therapy
Number of subjects: 87
Study: 10793877

Group type: EXPERIMENTAL
Intervention: Disodium pamidronate 300 mg/day for 4 weeks every 16 weeks (group A)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Disodium pamidronate 150 mg/day for 4 weeks every 8 weeks (group B)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Placebo (group C)
Number of subjects: 122
Study: 8992677

Group type: EXPERIMENTAL
Intervention: Cladribine orally for five days every four weeks, median of four series
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Observation period of 22 months with cladribine treatment
Number of subjects: 10
Study: 1450064

Group type: EXPERIMENTAL
Intervention: PAVe (procarbazine, Alkeran, vinblastine) and irradiation (RT)
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: PAVe/RT
Number of subjects: 159
Study: 3841315

Group type: EXPERIMENTAL
Intervention: 2 mg intrathecal morphine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 4 mg intrathecal morphine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 29687898

Group type: EXPERIMENTAL
Intervention: Low-frequency pulsed current (PC) NMES
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Medium-frequency current (MF) NMES
Number of subjects: 11

Group type: COMPARATOR
Intervention: Both PC and MF NMES
Number of subjects: 11
Study: 28343401

Group type: EXPERIMENTAL
Intervention: Probiotic (Bifidobacterium animalis subspecies lactis Bl‐04)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 26143234

Group type: EXPERIMENTAL
Intervention: 4 mm mini-tablet
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: syrup
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: suspension
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: powder
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: joint administration with food or drink
Number of subjects: 151
Study: 23520237

Group type: EXPERIMENTAL
Intervention: Transfer Package (TP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Transfer Package (TP) and training by shaping
Number of subjects: 40

Group type: COMPARATOR
Intervention: Weekly telephone contact (substudy)
Number of subjects: 40
Study: 21878843

Group type: EXPERIMENTAL
Intervention: Mifepristone 200 mg orally for up to 12 weeks
Number of subjects: 16
Study: 18543496

Group type: EXPERIMENTAL
Intervention: Massage with manipulation of supplementing marrow and kneading tendon (SMKT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rehabilitation training therapy alone (Control)
Number of subjects: 60
Study: 17073204

Group type: EXPERIMENTAL
Intervention: Scotchbond Multi‐Purpose (SMP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clearfil SE Bond (CSE)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between SMP and CSE
Number of subjects: 0
Study: 12969104

Group type: EXPERIMENTAL
Intervention: Epidural infusion containing ropivacaine (1 mg.ml‐1), fentanyl (2 micro g.ml‐1), and epinephrine (2 micro g.ml‐1) for group RFE.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Epidural infusion without epinephrine for group RF.
Number of subjects: 46
Study: 10717247

Group type: EXPERIMENTAL
Intervention: 120FEC (120 mg/m2 of epirubicin)
Number of subjects: 74

Group type: COMPARATOR
Intervention: 60FEC (60 mg/m2 of epirubicin)
Number of subjects: 74
Study: 9443096

Group type: EXPERIMENTAL
Intervention: VPA monotherapy
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: VPA polytherapy
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 41
Study: 8112200

Group type: EXPERIMENTAL
Intervention: DHEP plasters (diclofenac hydroxyethylpyrrolidine), 180 mg each, applied b.i.d. for 15 days
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: DHEP plasters
Number of subjects: 155

Group type: COMPARATOR
Intervention: Matched placebo (PBO)
Number of subjects: 155
Study: 3524418

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid (250 mg amoxicillin and 125 mg clavulanic acid) administered every 8 h for 10 days
Number of subjects: 107

Group type: COMPARATOR
Intervention: Cefaclor (250 mg) administered every 8 h for 10 days
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: Amoxicillin-clavulanic acid
Number of subjects: 107

Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 107
Study: 29607528

Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 28841828

Group type: EXPERIMENTAL
Intervention: Blink rate assessment during conversation, average blink rate for patients with DIP was 14 (SD 11), and for patients without DIP was 19 (SD 14).
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Blink rate cut-off of 20 blinks per minute.
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: 10% percentile cut-off model for blink rate.
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Logistic prediction model between dichotomous DIP and continuous blink rate per minute.
Number of subjects: 204
Study: 26552835

Group type: EXPERIMENTAL
Intervention: Noxipoint therapy (NT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Conventional physical therapy including transcutaneous electrical nerve stimulation (PT‐TENS)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: NT-like treatments
Number of subjects: 97
Study: 23668887

Group type: EXPERIMENTAL
Intervention: DTP booster vaccine
Number of subjects: 9
Study: 20583934

Group type: EXPERIMENTAL
Intervention: Single dose methotrexate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Multiple dose methotrexate
Number of subjects: 120
Study: 18218147

Group type: EXPERIMENTAL
Intervention: Magnesium treatment (500 mg divided into two tablets for 8 weeks)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 16247548

Group type: EXPERIMENTAL
Intervention: Therapeutic education plus conventional pharmacological treatment
Number of subjects: 43

Group type: COMPARATOR
Intervention: Conventional pharmacological treatment only
Number of subjects: 43
Study: 14615149

Group type: EXPERIMENTAL
Intervention: FSME-IMMUN "new" vaccine 0.6 microg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: FSME-IMMUN "new" vaccine 1.2 microg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: FSME-IMMUN "new" vaccine 2.4 microg
Number of subjects: 405

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 405
Study: 10768308

Group type: EXPERIMENTAL
Intervention: Topiramate (TPM)
Number of subjects: 97
Study: 8706313

Group type: EXPERIMENTAL
Intervention: Pretreatment (before treatment with methimazole)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Treated (after 11.2 ± 1.0 weeks treatment with methimazole)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Propranolol (20 mg thrice daily for 2 days)
Number of subjects: 12
Study: 7800160

Group type: EXPERIMENTAL
Intervention: Cocaine (60-80 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 7
Study: 3050587

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (n = 31)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Azathioprine (n = 43)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Both treatments (Cyclosporin A and Azathioprine)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Comparison of Cyclosporin A and Azathioprine
Number of subjects: 74
Study: 31615291

Group type: EXPERIMENTAL
Intervention: Rivaroxaban plus aspirin
Number of subjects: 27117

Group type: COMPARATOR
Intervention: Aspirin alone
Number of subjects: 27117
Study: 31356105

Group type: EXPERIMENTAL
Intervention: Maximal lung recruitment
Number of subjects: 115

Group type: COMPARATOR
Intervention: Control 'protective' ventilation
Number of subjects: 115
Study: 29145345

Group type: EXPERIMENTAL
Intervention: Sativex + Lokomat Training
Number of subjects: 40

Group type: COMPARATOR
Intervention: Other antispastic drug + Lokomat Training
Number of subjects: 40
Study: 25617992

Group type: EXPERIMENTAL
Intervention: FREE group (eye movements allowed)
Number of subjects: 0

Group type: COMPARATOR
Intervention: FIX group (eye movements restricted)
Number of subjects: 0
Study: 23434272

Group type: EXPERIMENTAL
Intervention: Non-elastic basketweave taping
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Elastic adhesive bandage wrap
Number of subjects: 12

Group type: COMPARATOR
Intervention: Non-taped control
Number of subjects: 12
Study: 21159143

Group type: EXPERIMENTAL
Intervention: Three courses of platinum-based chemotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Six courses of platinum-based chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systematic process changes at the outpatient clinic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy use in a national population
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Palliative chemotherapy
Number of subjects: 0
Study: 18337042

Group type: EXPERIMENTAL
Intervention: Weight-adjusted dose of 1.75 ml/kg
Number of subjects: 151

Group type: COMPARATOR
Intervention: Fixed dose of 120 ml of non-ionic contrast material (320 mg/ml)
Number of subjects: 151
Study: 17584356

Group type: EXPERIMENTAL
Intervention: Diabetes outpatient intensive management programme (DOIMP)
Number of subjects: 49
Study: 15332395

Group type: EXPERIMENTAL
Intervention: OK-432 and 30 mg of doxorubicin
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: OK-432 and doxorubicin
Number of subjects: 20
Study: 11293552

Group type: EXPERIMENTAL
Intervention: Fluvastatin XL 80 mg HS
Number of subjects: 1674

Group type: COMPARATOR
Intervention: Fluvastatin IR 40 mg HS
Number of subjects: 1674
Study: 9682649

Group type: EXPERIMENTAL
Intervention: Four-layer bandage (FLB)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Short stretch bandage (SSB)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Both FLB and SSB
Number of subjects: 53
Study: 7592505

Group type: EXPERIMENTAL
Intervention: Org 3770
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Amitriptyline
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 150
Study: 2312775

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/ZOK 100 mg once daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional Metoprolol Tablets (CT) 100 mg once daily
Number of subjects: 18

Group type: COMPARATOR
Intervention: Conventional Metoprolol Tablets (CT)
Number of subjects: 18
Study: 497315

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Pentobarbital
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Flurazepam
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 6
Study: 30982808

Group type: EXPERIMENTAL
Intervention: Theory-based health counselling in intervention group
Number of subjects: 15710

Group type: COMPARATOR
Intervention: Usual care standard counselling in usual care group
Number of subjects: 15710
Study: 31618382

Group type: EXPERIMENTAL
Intervention: PRENACEL program (communication program via short cellphone text messages)
Number of subjects: 1210

Group type: EXPERIMENTAL
Intervention: PRENACEL program
Number of subjects: 1210

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1210
Study: 27539149

Group type: EXPERIMENTAL
Intervention: SLActive implants
Number of subjects: 20

Group type: COMPARATOR
Intervention: SLA implants
Number of subjects: 20
Study: 26288392

Group type: EXPERIMENTAL
Intervention: Grape juice (10 mL/(kg·min) for 28 days)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Control beverage (isocaloric, isoglycemic, isovolumetric)
Number of subjects: 28
Study: 23220158

Group type: EXPERIMENTAL
Intervention: High-intensity intermittent exercise (HIIE) program three times per week for 12 weeks
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-intensity intermittent exercise (HIIE)
Number of subjects: 34
Study: 21702687

Group type: EXPERIMENTAL
Intervention: Preserved diclofenac sodium 0.1% (Voltaren Ophtha)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Preservative-free diclofenac (Dicloftil)
Number of subjects: 30
Study: 17999159

Group type: EXPERIMENTAL
Intervention: Lornoxicam (8 mg)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 62
Study: 17072691

Group type: EXPERIMENTAL
Intervention: 1.5 microg sufentanil
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 2.5 microg sufentanil
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 5.0 microg sufentanil
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (no sufentanil)
Number of subjects: 100
Study: 12930432

Group type: EXPERIMENTAL
Intervention: Tolterodine (twice daily for 16 weeks)
Number of subjects: 1380
Study: 10718389

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 80

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 80
Study: 1680813

Group type: EXPERIMENTAL
Intervention: 20 mg lisinopril
Number of subjects: 32

Group type: COMPARATOR
Intervention: 100 mg atenolol
Number of subjects: 32

Group type: COMPARATOR
Intervention: 20 mg nitrendipine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 7039760

Group type: EXPERIMENTAL
Intervention: Rosaramicin 250 mg six hourly for seven days
Number of subjects: 94

Group type: COMPARATOR
Intervention: Tetracycline 250 mg six hourly for seven days
Number of subjects: 94
Study: 31456562

Group type: EXPERIMENTAL
Intervention: Exercise therapy (7 sessions)
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Manual therapy (7 sessions)
Number of subjects: 615

Group type: COMPARATOR
Intervention: Single session of physiotherapy (SSPT)
Number of subjects: 615
Study: 29422473

Group type: EXPERIMENTAL
Intervention: Preoperative antibiotics at the time of admission
Number of subjects: 50

Group type: COMPARATOR
Intervention: Perioperative antibiotics at the time of induction of general anesthesia
Number of subjects: 50
Study: 27247220

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin/paclitaxel followed by neoadjuvant radiochemotherapy (RCT) to 45 Gy (1.5 Gy twice per day concurrent cisplatin/vinorelbine)
Number of subjects: 161
Study: 25194768

Group type: EXPERIMENTAL
Intervention: 1-day manipulation
Number of subjects: 43

Group type: COMPARATOR
Intervention: 7-day manipulation
Number of subjects: 43
Study: 22963812

Group type: EXPERIMENTAL
Intervention: NCX 4016 (800 mg, twice daily)
Number of subjects: 442

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 442
Study: 20372668

Group type: EXPERIMENTAL
Intervention: Tutoring peers in oral health (Part 2)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Adult toothbrushing technique (modified Bass technique) (Part 1)
Number of subjects: 49
Study: 18357917

Group type: EXPERIMENTAL
Intervention: Cytokine therapy using colony-stimulating factors (CSF) for bone marrow mobilisation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Local injection of monocyte chemoattractant protein 1 (MCP-1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of bone marrow mobilisation and MCP-1 injection
Number of subjects: 0
Study: 16192416

Group type: EXPERIMENTAL
Intervention: Amiloride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of amiloride and spironolactone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 12038846

Group type: EXPERIMENTAL
Intervention: Ultraporous beta-tricalcium phosphate (beta-TCP) combined with allograft and venous blood as an extender
Number of subjects: 7
Study: 10333091

Group type: EXPERIMENTAL
Intervention: Antioxidant supplementation (100 mg coenzyme Q10, 600 mg ascorbic acid, 270 mg alpha-tocopherol)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control phase (placebo)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Antioxidant phase
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo phase
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combined 31P‐NMRS/low frequency fatigue test
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Muscle fatigue at 10 Hz electrical stimulation
Number of subjects: 7
Study: 8613560

Group type: COMPARATOR
Intervention: 0.2% chlorhexidine
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Essential oil/phenolic rinse
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Anti-adhesive/chlorhexidine rinse
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Anti-adhesive rinse
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water rinse
Number of subjects: 15
Study: 2268915

Group type: EXPERIMENTAL
Intervention: Ginseng‐Rhizome saponin (GRS) 50 mg per tablet, three times a day for two months
Number of subjects: 358

Group type: COMPARATOR
Intervention: Placebo (starch)
Number of subjects: 358
Study: 6856487

Group type: EXPERIMENTAL
Intervention: Diflunisal
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Diflunisal 1,000 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin 650 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetaminophen 600 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propoxyphene napsylate 100 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acetaminophen with codeine 60 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propoxyphene with 100 mg
Number of subjects: 0
Study: 30664702

Group type: EXPERIMENTAL
Intervention: Anemic group (n=194)
Number of subjects: 1213

Group type: COMPARATOR
Intervention: Nonanemic group (n=1019)
Number of subjects: 1213

Group type: EXPERIMENTAL
Intervention: Overall hypertensive patients with well-controlled blood pressure
Number of subjects: 1213
Study: 29957314

Group type: EXPERIMENTAL
Intervention: Indirect bonding (group B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Direct bonding (group A)
Number of subjects: 30
Study: 26955675

Group type: EXPERIMENTAL
Intervention: Porous tantalum rod combined with Gugutou Huaisiyu Capsule (GHC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Porous tantalum rod
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Porous tantalum rod combined with GHC
Number of subjects: 50
Study: 24566538

Group type: EXPERIMENTAL
Intervention: Vascularized bone grafting (VBG) using the 1, 2 intercompartmental suprareticular artery
Number of subjects: 75

Group type: COMPARATOR
Intervention: Distal radius nonvascularized bone graft
Number of subjects: 75
Study: 22953794

Group type: EXPERIMENTAL
Intervention: Cardiac shock wave therapy (CSWT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo (acoustic simulation without energy application)
Number of subjects: 21
Study: 20308663

Group type: EXPERIMENTAL
Intervention: Combination therapy of docetaxel, bevacizumab, thalidomide, and prednisone
Number of subjects: 60
Study: 17965284

Group type: EXPERIMENTAL
Intervention: Enoximone
Number of subjects: 15
Study: 16150065

Group type: EXPERIMENTAL
Intervention: Intervention delivered by GPs focusing on nutrition, physical activity, and sedentary behaviour over 12 weeks in four consultations
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: General practitioners (GPs) trained in management of childhood overweight
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: BMI survey conducted by practice staff
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Recruitment of families for the LEAP RCT
Number of subjects: 163
Study: 12975277

Group type: EXPERIMENTAL
Intervention: Radioactive tracer (10 mCi of technetium 99m‐labeled macroaggregated albumin in 10 mL of physiologic saline)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (healthy controls)
Number of subjects: 25
Study: 10536315

Group type: EXPERIMENTAL
Intervention: Aspirin 30 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aspirin 81 mg
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aspirin 325 mg
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 9084524

Group type: EXPERIMENTAL
Intervention: Esmolol 2 mg/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Fentanyl 3 micrograms/kg
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Lidocaine 2 mg/kg
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 80
Study: 1745620

Group type: EXPERIMENTAL
Intervention: Cefepime 2 g every 12 hours plus metronidazole 500 mg every 6 hours intravenously
Number of subjects: 35

Group type: COMPARATOR
Intervention: Gentamicin 1.5 mg/kg plus clindamycin 900 mg every 8 hours intravenously
Number of subjects: 35
Study: 17152739

Group type: EXPERIMENTAL
Intervention: Ergotamine 1 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Metoclopramide 20 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ergotamine 1 mg + Metoclopramide 20 mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ergotamine 2 mg + Metoclopramide 20 mg
Number of subjects: 24
Study: 30663456

Group type: EXPERIMENTAL
Intervention: Trabecular micro-bypass stents (TBS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 0
Study: 27927009

Group type: EXPERIMENTAL
Intervention: Guardcel
Number of subjects: 32

Group type: COMPARATOR
Intervention: Merocel
Number of subjects: 32
Study: 27116364

Group type: EXPERIMENTAL
Intervention: Immediate treatment group (two, 150-minute group sessions spaced one-week apart)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 32
Study: 23520350

Group type: EXPERIMENTAL
Intervention: Guided imagery
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 65